Berahyaluronidase alfa (USAN/INN);
Berahyaluronidase alfa (genetical recombination) (JAN)

C2237H3403N573O647S17

49189.6250

49220.54

FRAPPVIPNV PFLWAWNAPS EFCLGKFDEP LDMSLFSFIG SPRINATGQG VTIFYVDRLG
YYPYIDSITG VTVNGGIPQK ISLQDHLDKA KKDITFYMPV DNLGMAVIDW EEWRPTWARN
WKPKDVYKNR SIELVQQQNV QLSLTEATEK AKQEFEKAGK DFLVETIKLG KLLRPNHLWG
YYLFPDCYNH HYKKPGYNGS CFNVEIKRND DLSWLWNEST ALYPSIYLNT QQSPVAATLY
VRNRVREAIR VSKIPDAKSP LPVFAYTRIV FTDQVLKFLS QDELVYTFGE TVALGASGIV
IWGSWENTRT KESCQAIKEY MDTTLNPYII NVTLAAKMCS QVLCQEQGVC IRKNWNSSDY
LHLNPDNFAI QLEKGGKFTV RGKPTLEDLE QFSEKFYCSC YSTLSCKEKA DVKDTDAVDV
CIADGVCIDA F
(Disulfide bridge: 23-314, 187-201, 339-350, 344-398, 400-406, 421-427)

Enzyme replacement (hyaluronidase)

Hyaluronidase (SPAM1, HYAL1, HYAL5) [HSA:6677] [KO:K01197] [EC:3.2.1.35] analog
Treatment of diseases that can be targeted by protein-based therapies